首页> 外文会议>Conference of the Spanish Association for Artificial Intelligence >Clinical Decision Support Using Antimicrobial Susceptibility Test Results
【24h】

Clinical Decision Support Using Antimicrobial Susceptibility Test Results

机译:使用抗菌药敏试验结果的临床决策支持

获取原文

摘要

Prescribing the proper antibiotic against an infectious agent is crucial not only for the patient's health but also for the community, due to fast development of new resistances in bacteria. To ensure the efficacy of the treatment, laboratory tests are performed on cultures of samples obtained from the patient, analysing the resistance patterns of the infectious microorganism against some antibiotics. In order to assist clinical microbiologists, the European Committee on Antimicrobial Susceptibility Testing proposes a catalogue of clinical rules to identify resistance patterns and clinical recommendations from the results of previous antibiotic susceptibility tests. The aim of our proposal is to automatise and evaluate this source of biomedical knowledge. To this end, we have implemented a knowledge module combining ontologies and production rules. This module was included in a clinical decision support system and evaluated using test results of 365 days. After its execution, 20.9 % of the final antibiograms were new resistance patterns not covered by the laboratory tests, having 44 % of them a high clinical evidence grade. These results could help clinicians to prescribe more efficient treatments against infections in the future.
机译:由于细菌中新的抗药性的快速发展,处方正确的抗生素抗感染剂不仅对患者的健康至关重要,而且对社区至关重要。为了确保治疗的有效性,对从患者那里获得的样本培养物进行了实验室测试,分析了感染性微生物对某些抗生素的耐药模式。为了协助临床微生物学家,欧洲抗菌药物敏感性试验委员会提出了一系列临床规则,以从先前的抗生素敏感性试验的结果中识别耐药性模式和临床建议。我们提议的目的是自动化和评估这种生物医学知识的来源。为此,我们实现了一个将本体和生产规则相结合的知识模块。该模块包含在临床决策支持系统中,并使用365天的测试结果进行了评估。执行后,最终抗菌素谱图的20.9%是实验室测试未涵盖的新耐药模式,其中44%具有较高的临床证据等级。这些结果可以帮助临床医生在将来开出更有效的抗感染治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号